360 MADISON AVENUE, NEW YORK, NY
Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
Provides Business Update and Reports Second Quarter 2026 Financial Results
Annual Meeting Results; Stockholders Elect Directors at Lucid Diagnostics
Provides Business Update and Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Announces Closing of $18 Million Underwritten Offering of Common Stock
Announces $18 Million Underwritten Offering of Common Stock
Earnings Release
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload